OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Toxicity Assesment


As per available reports about 17 Conferences, 74 Workshops and 9 Relevant Journals 1699 conference proceedings are presently dedicated exclusively to Toxicity Assessment and about 471 articles are being published on Toxicity Assessment.

Toxicity assessment  is mainly used to evaluate the available evidence regarding the potential of specific chemical substances which cause adverse effects in the individuals exposed. It also gives the relationship between the extent of exposure and its effects accordingly.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

OMICS International Conference Series focuses to enhance knowledge dissemination among its varied range of participants including eminent speakers, renowned scientists, industrialists from top notch companies, young researchers and students. OMICS International Pharma conferences foster the better understanding of latest scientific researches by providing a global exposure to its participants where they can associate with relatable professionals. The scope of these gatherings is  further extended by encompassing remarking key areas like Pharmaceutical Regulatory Affairs, Mass Spectrometry, Separation Techniques, Toxicology , Therapeutic Drug Monitoring and Toxicogenomics, Pain Medicine, Clinical Pharmacy, GMP and GLP quality control, followed by Bioavailability and Bioequivalence studies, Biosimilars and Pharmacognosy

Scope and Importance:

The toxicity assessment process is usually divided into two parts: the first characterizes and quantifies the non-cancer effects of the chemical, while the second addresses the cancer effects of the chemical. This two-part approach is employed because there are typically major differences in the time-course of action and the shape of the dose-response curve for cancer and non-cancer effects. Toxicity assessment is an integral part of the overall Superfund site risk assessment. Although toxicity information is critical to the risk assessment, the amount of new toxicological evaluation of primary data required to complete this step is limited in most cases. EPA has performed the toxicity assessment step for numerous chemicals and has made available the resulting toxicity information and toxicity values, which have undergone extensive peer review. At some sites, however, there will be significant data analysis and interpretation issues that should be addressed by an experienced toxicologist.

The conference on Toxicity assessment allows a scope for physicians, pharmacists, nurses, and scientists from around the world to participate in the sharing of knowledge on a wide variety of toxicity assessment topics and issues. In addition, there will be presentation of research papers, a number of symposia, as well as other traditional and novel continuing education sessions. .

Market Analysis:

An overview of the global toxicity testing market is obtained by analyses of market trends. The two major technology-based approaches utilised are mechanistic and nonmechanistic

In 2011, the global in vitro toxicity testing market was valued at $4 billion and more than $4.9 billion in 2012. This is estimated to reach around $9.9 billion in 2017, with a compound annual growth rate (CAGR) of 14.7% for the five-year period, 2012 to 2017.

 Influential factors for this estimation are alternative measures for toxicity and toxicity testing, validation of the techniques for chemicals, pesticides, and food additives.

A significant share of 32% is taken up by the pharmaceutical arena which is valued at $424 million in 2010. This sector is estimated to reach a value of $976 million, at a compound annual growth rate (CAGR) of 18.2%. by 2015.

List of Best International Conferences:

Societies:

Related Companies:

This page will be updated regularly.

This page was last updated on 15th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising